Roche Diagnostics FITC ANTI-LAMBDA PRIMARY ANTIBODY; ROCHGSK-05267951001

Roche Diagnostics Corporation FITC ANTI-LAMBDA PRIMARY ANTIBODY; This antibody is intended for in vitro diagnostic (IVD) use. Ventana Medical Systems, Inc. (Ventana) Systems FITC anti-Lambda Primary Antibody is a burro derived polyclonal antibody labeled with fluorescein and specifically directed against human lambda light chains. This reagent should be used in conjunction with a panel of antibodies to aid in the identification of lambda light chains in target tissue (e.g., in the diagnosis of renal or dermal pathologies). FITC anti-Lambda is intended for laboratory use to qualitatively stain sections of frozen tissue on a Ventana automated slide stainer. The clinical interpretation of any staining, or the absence of staining, must be complemented by morphological studies and evaluation of proper controls. Evaluation must be made by a qualified pathologist within the context of the patient’s clinical history and other diagnostic tests. Prescription only. 50 Tests - ROCHGSK (Additional S&H or Hazmat Fees May Apply)